glun2d Search Results


94
Alomone Labs polyclonal rabbit anti glun2d subunit
(A) Grin2d f l/fl mice were injected with AAV5-CamKII-mCherry (Control) or AAV-CamKII-mCherry-Cre ( Grin2d cKO). NMDAR-LTP was abolished in Grin2d cKO compared with control mice (Control: 149.5 ± 6.0 %, p < 0.01, n = 5, paired t-test; cKO: 92.5 ± 5.3 %, p = 0.12201, n = 6, paired t-test; Control vs cKO: p < 0.001, unpaired t-test). (B) WT mice were bilaterally injected with <t>an</t> <t>anti-GluN2D</t> antibody or control Ab into the dentate gyrus. After one hour, animals were euthanized, and slices were prepared. Injection was confirmed by the presence of methylene blue. NMDAR-LTP was abolished in mice injected with the anti-GluN2D antibody (cKO: 110.4 ± 8.5 %, p = 0.2952, n = 6, paired t-test) compared with control mice (Control: 149.8 ± 8.1 %, p < 0.001, n = 7, paired t-test; Control vs cKO: p < 0.01, unpaired t-test). (C) NMDAR-LTP was impaired in Grid1 KO mice (KO: 117.7 ± 5.3, p < 0.05%, n = 8, Wilcoxon signed-rank test) compared with controls (Control: 147.5 ± 6.7 %, p < 0.001, n = 7, paired t-test; Control vs cKO: p < 0.05, Mann-Whitney U test). Data are presented as mean ± s.e.m.
Polyclonal Rabbit Anti Glun2d Subunit, supplied by Alomone Labs, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/glun2d/bio_rxiv__64898__2026__03__06__710109-151-27-31?v=Alomone+Labs
Average 94 stars, based on 1 article reviews
polyclonal rabbit anti glun2d subunit - by Bioz Stars, 2026-08
94/100 stars
  Buy from Supplier

90
OriGene nr2d mr220972 subunits
Figure 2. (A) The chemical structure of ergotamine. (B) The H2O-injected oocytes did not cause any change with the treatment of 100 µM glutamate (n = 6–8 oocytes from four different frogs). (C–F) Glutamate induced inward currents with or without ergotamine (30 µM and 10 µM). For each subunit of NMDARs, the responses after treating with either glutamate (100 µM) alone or together with ergotamine (30 and 10 µM). Voltage clamp recording was conducted at a holding potential of −80 mV. The coapplication of ergotamine with glutamate resulted in modulation of the recombinant receptors (C) NR1a/NR2A, (D) NR1a/NR2B, (E) NR1a/NR2C, and (F) <t>NR1a/NR2D,</t> which in turn reduced glutamate-evoked inward current in a reversible manner (n = 6–8 oocytes from four different frogs).
Nr2d Mr220972 Subunits, supplied by OriGene, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/glun2d/pm36009192-48-19-26?v=OriGene
Average 90 stars, based on 1 article reviews
nr2d mr220972 subunits - by Bioz Stars, 2026-08
90/100 stars
  Buy from Supplier

93
OriGene plasmids
Figure 2. (A) The chemical structure of ergotamine. (B) The H2O-injected oocytes did not cause any change with the treatment of 100 µM glutamate (n = 6–8 oocytes from four different frogs). (C–F) Glutamate induced inward currents with or without ergotamine (30 µM and 10 µM). For each subunit of NMDARs, the responses after treating with either glutamate (100 µM) alone or together with ergotamine (30 and 10 µM). Voltage clamp recording was conducted at a holding potential of −80 mV. The coapplication of ergotamine with glutamate resulted in modulation of the recombinant receptors (C) NR1a/NR2A, (D) NR1a/NR2B, (E) NR1a/NR2C, and (F) <t>NR1a/NR2D,</t> which in turn reduced glutamate-evoked inward current in a reversible manner (n = 6–8 oocytes from four different frogs).
Plasmids, supplied by OriGene, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/glun2d/pm41005304-332-7-19?v=OriGene
Average 93 stars, based on 1 article reviews
plasmids - by Bioz Stars, 2026-08
93/100 stars
  Buy from Supplier

90
OriGene nr2d glun2d subunit
Figure 2. (A) The chemical structure of ergotamine. (B) The H2O-injected oocytes did not cause any change with the treatment of 100 µM glutamate (n = 6–8 oocytes from four different frogs). (C–F) Glutamate induced inward currents with or without ergotamine (30 µM and 10 µM). For each subunit of NMDARs, the responses after treating with either glutamate (100 µM) alone or together with ergotamine (30 and 10 µM). Voltage clamp recording was conducted at a holding potential of −80 mV. The coapplication of ergotamine with glutamate resulted in modulation of the recombinant receptors (C) NR1a/NR2A, (D) NR1a/NR2B, (E) NR1a/NR2C, and (F) <t>NR1a/NR2D,</t> which in turn reduced glutamate-evoked inward current in a reversible manner (n = 6–8 oocytes from four different frogs).
Nr2d Glun2d Subunit, supplied by OriGene, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/glun2d/pmc05600142-70-32-50?v=OriGene
Average 90 stars, based on 1 article reviews
nr2d glun2d subunit - by Bioz Stars, 2026-08
90/100 stars
  Buy from Supplier

86
Boster Bio rabbit anti nmdar antibodies
Figure 2. (A) The chemical structure of ergotamine. (B) The H2O-injected oocytes did not cause any change with the treatment of 100 µM glutamate (n = 6–8 oocytes from four different frogs). (C–F) Glutamate induced inward currents with or without ergotamine (30 µM and 10 µM). For each subunit of NMDARs, the responses after treating with either glutamate (100 µM) alone or together with ergotamine (30 and 10 µM). Voltage clamp recording was conducted at a holding potential of −80 mV. The coapplication of ergotamine with glutamate resulted in modulation of the recombinant receptors (C) NR1a/NR2A, (D) NR1a/NR2B, (E) NR1a/NR2C, and (F) <t>NR1a/NR2D,</t> which in turn reduced glutamate-evoked inward current in a reversible manner (n = 6–8 oocytes from four different frogs).
Rabbit Anti Nmdar Antibodies, supplied by Boster Bio, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/glun2d/pm28944854-57-5-11?v=Boster+Bio
Average 86 stars, based on 1 article reviews
rabbit anti nmdar antibodies - by Bioz Stars, 2026-08
86/100 stars
  Buy from Supplier

90
Chantest Inc glun2c-hek cell lines
Figure 2. (A) The chemical structure of ergotamine. (B) The H2O-injected oocytes did not cause any change with the treatment of 100 µM glutamate (n = 6–8 oocytes from four different frogs). (C–F) Glutamate induced inward currents with or without ergotamine (30 µM and 10 µM). For each subunit of NMDARs, the responses after treating with either glutamate (100 µM) alone or together with ergotamine (30 and 10 µM). Voltage clamp recording was conducted at a holding potential of −80 mV. The coapplication of ergotamine with glutamate resulted in modulation of the recombinant receptors (C) NR1a/NR2A, (D) NR1a/NR2B, (E) NR1a/NR2C, and (F) <t>NR1a/NR2D,</t> which in turn reduced glutamate-evoked inward current in a reversible manner (n = 6–8 oocytes from four different frogs).
Glun2c Hek Cell Lines, supplied by Chantest Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/glun2d/pm29454156-52-3-18?v=Chantest+Inc
Average 90 stars, based on 1 article reviews
glun2c-hek cell lines - by Bioz Stars, 2026-08
90/100 stars
  Buy from Supplier

90
GenScript corporation cdna encoding the glun2c and glun2d
Figure 2. (A) The chemical structure of ergotamine. (B) The H2O-injected oocytes did not cause any change with the treatment of 100 µM glutamate (n = 6–8 oocytes from four different frogs). (C–F) Glutamate induced inward currents with or without ergotamine (30 µM and 10 µM). For each subunit of NMDARs, the responses after treating with either glutamate (100 µM) alone or together with ergotamine (30 and 10 µM). Voltage clamp recording was conducted at a holding potential of −80 mV. The coapplication of ergotamine with glutamate resulted in modulation of the recombinant receptors (C) NR1a/NR2A, (D) NR1a/NR2B, (E) NR1a/NR2C, and (F) <t>NR1a/NR2D,</t> which in turn reduced glutamate-evoked inward current in a reversible manner (n = 6–8 oocytes from four different frogs).
Cdna Encoding The Glun2c And Glun2d, supplied by GenScript corporation, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/glun2d/pmc10245146-37-41-45?v=GenScript+corporation
Average 90 stars, based on 1 article reviews
cdna encoding the glun2c and glun2d - by Bioz Stars, 2026-08
90/100 stars
  Buy from Supplier

90
BioResource International Inc homozygous male mutant mice lacking the glun2d subunit of nmdar
Active immunization selectively prevents tPA/GluN1 interaction and tPA-induced enhancement of <t>NMDAR</t> signaling without altering the basal Ca2+ conductivity. A, Schematic representation of NMDAR composed <t>of</t> <t>GluN1/GluN2D</t> subunits, including binding sites of αATD–GluN1, αCTD–GluN1, and αCTD–GluN2D antibodies, UBP145, and tPA. B, ATD–GluN1 immunized mice display antibodies specifically targeting the GluN1 subunit of NMDAR. Proteins extracts from naive mouse brain (n = 3) were subjected to immunoblots revealed with IgGs purified from either control mice (control IgGs) or ATD–GluN1 (120 kDa) immunized mice (αATD–GluN1). Parallel immunoblottings were performed and revealed with antibodies raised against either CTD–GluN1 (named αCTD–GluN1), known to reveal a band at ∼120 kDa, or CTD–GluN2D (named αCTD–GluN2D), known to reveal a band at ∼165 kDa. C, After immunization, mice display circulating antibodies against GluN1, capable of preventing the potentiating effect of tPA on GluN1/GluN2D subunit-containing NMDARs. NMDA induces Ca2+ influx in cortical neurons as measured by fura-2 video microscopy (N = 3, n = 150 cells). Coapplication of tPA (20 μg/ml; 45 min) potentiates the NMDA-evoked Ca2+ influx by 47% (N = 3, n = 108 cells). Neither UBP145 alone (0.2 μm; N = 3, n = 150 cells) nor αATD–GluN1 antibodies alone (0.01 mg/ml; N = 3, n = 108 cells) alter NMDA-induced Ca2+ influx. Both UBP145 (0.2 μm) and αATD–GluN1 (0.01 mg/ml) are capable of blocking this potentiating effect of tPA (N = 3, n = 150 cells and N = 3, n = 108 cells, respectively). Ctrl, Control; HBBSS, serum-free medium. Paired Student's t test (before vs after treatment), *p < 0.001. Vertical bars indicate SD.
Homozygous Male Mutant Mice Lacking The Glun2d Subunit Of Nmdar, supplied by BioResource International Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/glun2d/pmc06703808-27-10-32?v=BioResource+International+Inc
Average 90 stars, based on 1 article reviews
homozygous male mutant mice lacking the glun2d subunit of nmdar - by Bioz Stars, 2026-08
90/100 stars
  Buy from Supplier

86
Charles River Laboratories glun1 glun2d
Active immunization selectively prevents tPA/GluN1 interaction and tPA-induced enhancement of <t>NMDAR</t> signaling without altering the basal Ca2+ conductivity. A, Schematic representation of NMDAR composed <t>of</t> <t>GluN1/GluN2D</t> subunits, including binding sites of αATD–GluN1, αCTD–GluN1, and αCTD–GluN2D antibodies, UBP145, and tPA. B, ATD–GluN1 immunized mice display antibodies specifically targeting the GluN1 subunit of NMDAR. Proteins extracts from naive mouse brain (n = 3) were subjected to immunoblots revealed with IgGs purified from either control mice (control IgGs) or ATD–GluN1 (120 kDa) immunized mice (αATD–GluN1). Parallel immunoblottings were performed and revealed with antibodies raised against either CTD–GluN1 (named αCTD–GluN1), known to reveal a band at ∼120 kDa, or CTD–GluN2D (named αCTD–GluN2D), known to reveal a band at ∼165 kDa. C, After immunization, mice display circulating antibodies against GluN1, capable of preventing the potentiating effect of tPA on GluN1/GluN2D subunit-containing NMDARs. NMDA induces Ca2+ influx in cortical neurons as measured by fura-2 video microscopy (N = 3, n = 150 cells). Coapplication of tPA (20 μg/ml; 45 min) potentiates the NMDA-evoked Ca2+ influx by 47% (N = 3, n = 108 cells). Neither UBP145 alone (0.2 μm; N = 3, n = 150 cells) nor αATD–GluN1 antibodies alone (0.01 mg/ml; N = 3, n = 108 cells) alter NMDA-induced Ca2+ influx. Both UBP145 (0.2 μm) and αATD–GluN1 (0.01 mg/ml) are capable of blocking this potentiating effect of tPA (N = 3, n = 150 cells and N = 3, n = 108 cells, respectively). Ctrl, Control; HBBSS, serum-free medium. Paired Student's t test (before vs after treatment), *p < 0.001. Vertical bars indicate SD.
Glun1 Glun2d, supplied by Charles River Laboratories, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/glun2d/10__1113_slash_jp282107-58-58-65?v=Charles+River+Laboratories
Average 86 stars, based on 1 article reviews
glun1 glun2d - by Bioz Stars, 2026-08
86/100 stars
  Buy from Supplier

N/A
Standard format: Plasmid sent in bacteria as agar stab
  Buy from Supplier

Image Search Results


(A) Grin2d f l/fl mice were injected with AAV5-CamKII-mCherry (Control) or AAV-CamKII-mCherry-Cre ( Grin2d cKO). NMDAR-LTP was abolished in Grin2d cKO compared with control mice (Control: 149.5 ± 6.0 %, p < 0.01, n = 5, paired t-test; cKO: 92.5 ± 5.3 %, p = 0.12201, n = 6, paired t-test; Control vs cKO: p < 0.001, unpaired t-test). (B) WT mice were bilaterally injected with an anti-GluN2D antibody or control Ab into the dentate gyrus. After one hour, animals were euthanized, and slices were prepared. Injection was confirmed by the presence of methylene blue. NMDAR-LTP was abolished in mice injected with the anti-GluN2D antibody (cKO: 110.4 ± 8.5 %, p = 0.2952, n = 6, paired t-test) compared with control mice (Control: 149.8 ± 8.1 %, p < 0.001, n = 7, paired t-test; Control vs cKO: p < 0.01, unpaired t-test). (C) NMDAR-LTP was impaired in Grid1 KO mice (KO: 117.7 ± 5.3, p < 0.05%, n = 8, Wilcoxon signed-rank test) compared with controls (Control: 147.5 ± 6.7 %, p < 0.001, n = 7, paired t-test; Control vs cKO: p < 0.05, Mann-Whitney U test). Data are presented as mean ± s.e.m.

Journal: bioRxiv

Article Title: GluN2D-containing NMDA receptors regulate dentate gyrus function by facilitating granule cell activity and mediating synaptic plasticity

doi: 10.64898/2026.03.06.710109

Figure Lengend Snippet: (A) Grin2d f l/fl mice were injected with AAV5-CamKII-mCherry (Control) or AAV-CamKII-mCherry-Cre ( Grin2d cKO). NMDAR-LTP was abolished in Grin2d cKO compared with control mice (Control: 149.5 ± 6.0 %, p < 0.01, n = 5, paired t-test; cKO: 92.5 ± 5.3 %, p = 0.12201, n = 6, paired t-test; Control vs cKO: p < 0.001, unpaired t-test). (B) WT mice were bilaterally injected with an anti-GluN2D antibody or control Ab into the dentate gyrus. After one hour, animals were euthanized, and slices were prepared. Injection was confirmed by the presence of methylene blue. NMDAR-LTP was abolished in mice injected with the anti-GluN2D antibody (cKO: 110.4 ± 8.5 %, p = 0.2952, n = 6, paired t-test) compared with control mice (Control: 149.8 ± 8.1 %, p < 0.001, n = 7, paired t-test; Control vs cKO: p < 0.01, unpaired t-test). (C) NMDAR-LTP was impaired in Grid1 KO mice (KO: 117.7 ± 5.3, p < 0.05%, n = 8, Wilcoxon signed-rank test) compared with controls (Control: 147.5 ± 6.7 %, p < 0.001, n = 7, paired t-test; Control vs cKO: p < 0.05, Mann-Whitney U test). Data are presented as mean ± s.e.m.

Article Snippet: For GluN2D cross-linking experiments in C57BL/6J, the control group received 1 μL of anti-rabbit Alexa 568 (control IgG, 1/5), while the GluN2D-cross-link group received 1 μg of polyclonal rabbit anti-GluN2D subunit (Alomone Labs, cat #AGC-020), both diluted in PBS with 1% methylene blue (1 μL final volume).

Techniques: Injection, Control, MANN-WHITNEY

Figure 2. (A) The chemical structure of ergotamine. (B) The H2O-injected oocytes did not cause any change with the treatment of 100 µM glutamate (n = 6–8 oocytes from four different frogs). (C–F) Glutamate induced inward currents with or without ergotamine (30 µM and 10 µM). For each subunit of NMDARs, the responses after treating with either glutamate (100 µM) alone or together with ergotamine (30 and 10 µM). Voltage clamp recording was conducted at a holding potential of −80 mV. The coapplication of ergotamine with glutamate resulted in modulation of the recombinant receptors (C) NR1a/NR2A, (D) NR1a/NR2B, (E) NR1a/NR2C, and (F) NR1a/NR2D, which in turn reduced glutamate-evoked inward current in a reversible manner (n = 6–8 oocytes from four different frogs).

Journal: Antioxidants (Basel, Switzerland)

Article Title: The Application of the Neuroprotective and Potential Antioxidant Effect of Ergotamine Mediated by Targeting N-Methyl-D-Aspartate Receptors.

doi: 10.3390/antiox11081471

Figure Lengend Snippet: Figure 2. (A) The chemical structure of ergotamine. (B) The H2O-injected oocytes did not cause any change with the treatment of 100 µM glutamate (n = 6–8 oocytes from four different frogs). (C–F) Glutamate induced inward currents with or without ergotamine (30 µM and 10 µM). For each subunit of NMDARs, the responses after treating with either glutamate (100 µM) alone or together with ergotamine (30 and 10 µM). Voltage clamp recording was conducted at a holding potential of −80 mV. The coapplication of ergotamine with glutamate resulted in modulation of the recombinant receptors (C) NR1a/NR2A, (D) NR1a/NR2B, (E) NR1a/NR2C, and (F) NR1a/NR2D, which in turn reduced glutamate-evoked inward current in a reversible manner (n = 6–8 oocytes from four different frogs).

Article Snippet: The mouse NMDAR subunit cDNAs included the NR1 (GenBank accession number: MR225704), NR2A (MR227135), NR2B (MR227077), NR2C (MR222676), and NR2D (MR220972) subunits, which were purchased from OriGene (Rockville, MD, USA).

Techniques: Injection, Recombinant

Active immunization selectively prevents tPA/GluN1 interaction and tPA-induced enhancement of NMDAR signaling without altering the basal Ca2+ conductivity. A, Schematic representation of NMDAR composed of GluN1/GluN2D subunits, including binding sites of αATD–GluN1, αCTD–GluN1, and αCTD–GluN2D antibodies, UBP145, and tPA. B, ATD–GluN1 immunized mice display antibodies specifically targeting the GluN1 subunit of NMDAR. Proteins extracts from naive mouse brain (n = 3) were subjected to immunoblots revealed with IgGs purified from either control mice (control IgGs) or ATD–GluN1 (120 kDa) immunized mice (αATD–GluN1). Parallel immunoblottings were performed and revealed with antibodies raised against either CTD–GluN1 (named αCTD–GluN1), known to reveal a band at ∼120 kDa, or CTD–GluN2D (named αCTD–GluN2D), known to reveal a band at ∼165 kDa. C, After immunization, mice display circulating antibodies against GluN1, capable of preventing the potentiating effect of tPA on GluN1/GluN2D subunit-containing NMDARs. NMDA induces Ca2+ influx in cortical neurons as measured by fura-2 video microscopy (N = 3, n = 150 cells). Coapplication of tPA (20 μg/ml; 45 min) potentiates the NMDA-evoked Ca2+ influx by 47% (N = 3, n = 108 cells). Neither UBP145 alone (0.2 μm; N = 3, n = 150 cells) nor αATD–GluN1 antibodies alone (0.01 mg/ml; N = 3, n = 108 cells) alter NMDA-induced Ca2+ influx. Both UBP145 (0.2 μm) and αATD–GluN1 (0.01 mg/ml) are capable of blocking this potentiating effect of tPA (N = 3, n = 150 cells and N = 3, n = 108 cells, respectively). Ctrl, Control; HBBSS, serum-free medium. Paired Student's t test (before vs after treatment), *p < 0.001. Vertical bars indicate SD.

Journal: The Journal of Neuroscience

Article Title: GluN2D Subunit-Containing NMDA Receptors Control Tissue Plasminogen Activator-Mediated Spatial Memory

doi: 10.1523/JNEUROSCI.6202-11.2012

Figure Lengend Snippet: Active immunization selectively prevents tPA/GluN1 interaction and tPA-induced enhancement of NMDAR signaling without altering the basal Ca2+ conductivity. A, Schematic representation of NMDAR composed of GluN1/GluN2D subunits, including binding sites of αATD–GluN1, αCTD–GluN1, and αCTD–GluN2D antibodies, UBP145, and tPA. B, ATD–GluN1 immunized mice display antibodies specifically targeting the GluN1 subunit of NMDAR. Proteins extracts from naive mouse brain (n = 3) were subjected to immunoblots revealed with IgGs purified from either control mice (control IgGs) or ATD–GluN1 (120 kDa) immunized mice (αATD–GluN1). Parallel immunoblottings were performed and revealed with antibodies raised against either CTD–GluN1 (named αCTD–GluN1), known to reveal a band at ∼120 kDa, or CTD–GluN2D (named αCTD–GluN2D), known to reveal a band at ∼165 kDa. C, After immunization, mice display circulating antibodies against GluN1, capable of preventing the potentiating effect of tPA on GluN1/GluN2D subunit-containing NMDARs. NMDA induces Ca2+ influx in cortical neurons as measured by fura-2 video microscopy (N = 3, n = 150 cells). Coapplication of tPA (20 μg/ml; 45 min) potentiates the NMDA-evoked Ca2+ influx by 47% (N = 3, n = 108 cells). Neither UBP145 alone (0.2 μm; N = 3, n = 150 cells) nor αATD–GluN1 antibodies alone (0.01 mg/ml; N = 3, n = 108 cells) alter NMDA-induced Ca2+ influx. Both UBP145 (0.2 μm) and αATD–GluN1 (0.01 mg/ml) are capable of blocking this potentiating effect of tPA (N = 3, n = 150 cells and N = 3, n = 108 cells, respectively). Ctrl, Control; HBBSS, serum-free medium. Paired Student's t test (before vs after treatment), *p < 0.001. Vertical bars indicate SD.

Article Snippet: Subjects Homozygous male mutant mice lacking the GluN2D subunit of NMDAR were generated by Prof. Mishina (University of Tokyo, Tokyo, Japan) ( Ikeda et al., 1995 ) and provided by the RIKEN BioResource Center.

Techniques: Binding Assay, Western Blot, Purification, Control, Microscopy, Blocking Assay

Regulation of NMDAR subunits (GluN1, GluN2A, GluN2B, GluN2D) in hippocampus after active immunization against the ATD of the NMDAR GluN1 subunit. Relative mRNA quantity, estimated by RT-qPCR, was expressed in 2−(Ct gene of interest), in which Ct is the threshold cycle value. A, GluN1 subunit mRNA expression. B, GluN2A subunit mRNA expression. C, GluN2B subunit mRNA expression. D, GluN2D subunit mRNA expression. WT Crude ATD mice, n = 5; WT Crude Control mice, n = 5. Mann–Whitney U test, *p < 0.05. Vertical bars indicate SD.

Journal: The Journal of Neuroscience

Article Title: GluN2D Subunit-Containing NMDA Receptors Control Tissue Plasminogen Activator-Mediated Spatial Memory

doi: 10.1523/JNEUROSCI.6202-11.2012

Figure Lengend Snippet: Regulation of NMDAR subunits (GluN1, GluN2A, GluN2B, GluN2D) in hippocampus after active immunization against the ATD of the NMDAR GluN1 subunit. Relative mRNA quantity, estimated by RT-qPCR, was expressed in 2−(Ct gene of interest), in which Ct is the threshold cycle value. A, GluN1 subunit mRNA expression. B, GluN2A subunit mRNA expression. C, GluN2B subunit mRNA expression. D, GluN2D subunit mRNA expression. WT Crude ATD mice, n = 5; WT Crude Control mice, n = 5. Mann–Whitney U test, *p < 0.05. Vertical bars indicate SD.

Article Snippet: Subjects Homozygous male mutant mice lacking the GluN2D subunit of NMDAR were generated by Prof. Mishina (University of Tokyo, Tokyo, Japan) ( Ikeda et al., 1995 ) and provided by the RIKEN BioResource Center.

Techniques: Quantitative RT-PCR, Expressing, Control, MANN-WHITNEY

GluN1/GluN2D subunit-containing NMDARs drive tPA-influenced spatial memory. A, Previous studies have evidenced that tPA was not involved in locomotor activity (Pawlak et al., 2002). However, tPA is known to influence both emotional (Calabresi et al., 2000) and spatial memories (Benchenane et al., 2007). B, Our present experiments reveal that inhibition of the tPA/NMDAR interaction prevents neither locomotor activity nor emotional memory in mice. In addition, our results show that the tPA/NMDAR interaction is a critical mechanism underlying tPA-influenced spatial memory. C, In agreement with Ikeda et al. (1995), we observe a decrease in spontaneous locomotor activity in GluN2D-deficient mice. Furthermore, our present study reveals impairments of both emotional and spatial memories in this strain. In addition, we also show that the inhibition of tPA/NMDAR interaction does not impair the spatial memory in GluN2D KO mice. Together, these results demonstrate that tPA influences spatial memory through an increased affinity for NMDAR when associated with GluN2D subunit. Arrows point to the behavioral deficit.

Journal: The Journal of Neuroscience

Article Title: GluN2D Subunit-Containing NMDA Receptors Control Tissue Plasminogen Activator-Mediated Spatial Memory

doi: 10.1523/JNEUROSCI.6202-11.2012

Figure Lengend Snippet: GluN1/GluN2D subunit-containing NMDARs drive tPA-influenced spatial memory. A, Previous studies have evidenced that tPA was not involved in locomotor activity (Pawlak et al., 2002). However, tPA is known to influence both emotional (Calabresi et al., 2000) and spatial memories (Benchenane et al., 2007). B, Our present experiments reveal that inhibition of the tPA/NMDAR interaction prevents neither locomotor activity nor emotional memory in mice. In addition, our results show that the tPA/NMDAR interaction is a critical mechanism underlying tPA-influenced spatial memory. C, In agreement with Ikeda et al. (1995), we observe a decrease in spontaneous locomotor activity in GluN2D-deficient mice. Furthermore, our present study reveals impairments of both emotional and spatial memories in this strain. In addition, we also show that the inhibition of tPA/NMDAR interaction does not impair the spatial memory in GluN2D KO mice. Together, these results demonstrate that tPA influences spatial memory through an increased affinity for NMDAR when associated with GluN2D subunit. Arrows point to the behavioral deficit.

Article Snippet: Subjects Homozygous male mutant mice lacking the GluN2D subunit of NMDAR were generated by Prof. Mishina (University of Tokyo, Tokyo, Japan) ( Ikeda et al., 1995 ) and provided by the RIKEN BioResource Center.

Techniques: Activity Assay, Inhibition